AndrewMichaelKazMD
Gastroenterology • Seattle, WAAssociate Professor, Medicine, University of Washington School of Medicine
Dr. Kaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1660 S. Columbian Way
S-111-Gastro
Seattle, WA 98108Phone+1 206-764-2285- Is this information wrong?
Education & Training
University of WashingtonFellowship, Gastroenterology, 2003 - 2007
University of Michigan Health SystemResidency, Internal Medicine, 1999 - 2002
Duke University School of MedicineClass of 1999
Certifications & Licensure
WA State Medical License 2003 - 2026
MI State Medical License 1999 - 2006- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Start of enrollment: 2012 Apr 30
- A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors Start of enrollment: 2012 Aug 13
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Publications & Presentations
PubMed
- 1 citationsNovel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-Grade Dysplasia.Ming Yu, Helen R Moinova, Amber Willbanks, Victoria K Cannon, Ting Wang, Kelly Carter, Andrew Kaz, Deepti Reddi, John Inadomi, Georg Luebeck, Prasad G Iyer, Marcia I C...> ;Clinical Cancer Research. 2022 Sep 1
- 12 citationsEpigenetic Inactivation of α-Internexin Accelerates Microtubule Polymerization in Colorectal Cancer.Yingjie Li, Liangliang Bai, Huichuan Yu, Du Cai, Xiaolin Wang, Baoyuan Huang, Shaoyong Peng, Meijin Huang, Guangwen Cao, Andrew M. Kaz, William M. Grady, Jianping Wang...> ;Cancer Research. 2020 Dec 1
- 6 citationsChemoprevention of esophageal adenocarcinoma.Erik J. Snider, Andrew M. Kaz, John M. Inadomi, William M. Grady> ;Gastroenterology Report. 2020 Jul 24
- Join now to see all
Press Mentions
Novel Barrett’s Esophagus Screening Assays Based on Swallowable Devices: Will They Change the Game?April 1st, 2019
Grant Support
- Methylated DNA Biomarkers For Barrett'S Esophagus And Esophageal AdenocarcinomaNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Hospital Affiliations
Seattle VA Medical CenterSeattle, Washington
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
